Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:25468678  

A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity.

Peter I Joyce | Philip Mcgoldrick | Rachele A Saccon | William Weber | Pietro Fratta | Steven J West | Ning Zhu | Sarah Carter | Vinaya Phatak | Michelle Stewart | Michelle Simon | Saumya Kumar | Ines Heise | Virginie Bros-Facer | James Dick | Silvia Corrochano | Macdonnell J Stanford | Tu Vinh Luong | Patrick M Nolan | Timothy Meyer | Sebastian Brandner | David L H Bennett | P Hande Ozdinler | Linda Greensmith | Elizabeth M C Fisher | Abraham Acevedo-Arozena
Human molecular genetics | 2015

Transgenic mouse models expressing mutant superoxide dismutase 1 (SOD1) have been critical in furthering our understanding of amyotrophic lateral sclerosis (ALS). However, such models generally overexpress the mutant protein, which may give rise to phenotypes not directly relevant to the disorder. Here, we have analysed a novel mouse model that has a point mutation in the endogenous mouse Sod1 gene; this mutation is identical to a pathological change in human familial ALS (fALS) which results in a D83G change in SOD1 protein. Homozgous Sod1(D83G/D83G) mice develop progressive degeneration of lower (LMN) and upper motor neurons, likely due to the same unknown toxic gain of function as occurs in human fALS cases, but intriguingly LMN cell death appears to stop in early adulthood and the mice do not become paralyzed. The D83 residue coordinates zinc binding, and the D83G mutation results in loss of dismutase activity and SOD1 protein instability. As a result, Sod1(D83G/D83G) mice also phenocopy the distal axonopathy and hepatocellular carcinoma found in Sod1 null mice (Sod1(-/-)). These unique mice allow us to further our understanding of ALS by separating the central motor neuron body degeneration and the peripheral effects from a fALS mutation expressed at endogenous levels.

Pubmed ID: 25468678

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: Medical Research Council, United Kingdom
    Id: MR/M008606/1
  • Agency: Medical Research Council, United Kingdom
    Id: MC_UP_A390_1106
  • Agency: Motor Neurone Disease Association, United Kingdom
    Id: FRATTA/JAN15/946-795
  • Agency: Wellcome Trust, United Kingdom
    Id: 102645
  • Agency: Medical Research Council, United Kingdom
    Id: G0500288
  • Agency: Wellcome Trust, United Kingdom
    Id: 095698
  • Agency: Medical Research Council, United Kingdom
    Id: G1000287
  • Agency: Medical Research Council, United Kingdom
    Id: MR/K018523/1

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions